Skip to main content
Equibles
SCND logo

SCND · Scientific Industries Inc · Metrics

Track SCND — free

Use SCND with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SCND.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.78 At close · Sep 30
Rebalance outlook locked
Going-concern doubt — cleared Aug 14, 2026

The latest filing states the doubt was alleviated.

“The Company has evaluated whether there are certain conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for at least one year after the date the Unaudited Condensed Consolidated Financial Statements are issued.”
View the 10-Q filed Aug 14, 2026
Customer concentration — top 2 customers 49% of revenue

2 customers — 49% of revenue (the three months ended June 30, 2026)

“For the three months ended June 30, 2026, two customers accounted for approximately 49% of the Company’s total revenue.”

2 customers — 35% of revenue (the six months ended June 30, 2026)

“For the six months ended June 30, 2026, two customers accounted for approximately 35% of the Company’s total revenue.”

One customer — 10% of revenue (the six months ending June 30, 2025)

“For the six months ending June 30, 2025, one customer accounted for approximately 10% of the Company’s total revenue.”

One customer — 10% of revenue (the three months ending June 30, 2025)

“For the three months ending June 30, 2025, one customer accounted for approximately 10% of the Company’s total revenue.”
View the 10-Q filed Aug 14, 2026
Market Cap
$8.95M
Shares
11.93M
Volume · Sep 30 7500 Avg daily vol (3M) 4169

SCND metrics

62 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.78
Market cap
$8.95M

Price action

20 metrics
Price change (1W)
+3.5%
Price change (30D)
-11.3%
Price change (3M)
+33.9%
Price change (6M)
+5.8%
Price change (YTD)
+38.7%
Price change (1Y)
+10.9%
Trailing year
Price change (5Y)
-86.5%
52-week high
$0.88
52-week low
$0.46
Change from 52-week high
-11.3%
Change from 52-week low
+67.4%
Annualized volatility
164.5%
Annualized volatility (3M)
—
Beta
0.9
RSI (14D)
52.9
Price vs SMA 50
+10.6%
Price vs SMA 200
+8.2%
Avg volume (3M)
4,169
Relative volume
1.8
Average dollar volume
$2,966

Company

3 metrics
Sector
Technology
Industry
Scientific & Technical Instruments
Shares outstanding
11.93M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.6×
reciprocal yield 64.0%
P / book
1.1
reciprocal yield 90.3%
FCF yield
-77.0%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-8.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
4.2×
reciprocal yield 24.1%
EV / revenue historical average (5Y)
4.2×
reciprocal yield 24.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.4%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
29.2%
Operating margin
-120.8%
Trailing 12 months
Net margin
-12.9%
Gross profit (TTM)
$1.67M
Operating profit (TTM)
−$6.92M
Net income (TTM)
−$741,300
Trailing 12 months
Diluted EPS (TTM)
$-0.05
FCF margin
-120.2%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.89

Growth

11 metrics
Revenue growth YoY
+36.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$5.73M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+5.1%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-9.2%
Return on assets
-7.3%
Debt / equity
—
Current ratio
5.1
EBITDA (TTM)
−$6.53M
Free cash flow (TTM)
−$6.89M
Quick ratio
3.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$616,500
Total assets
$10.11M
Total debt
$433,800

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$6.84M
Capital expenditures (TTM)
$44,500
R&D (TTM)
$2.56M
SG&A (TTM)
—
Stock compensation (TTM)
$424,300
R&D / revenue
44.6%
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 4.6 days to cover
Days to cover
4.6d
Short-squeeze score
40 / 100

Insider activity

2 metrics
Net insider buying (90D)
$14,255
Insider-sentiment score
79 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 87802 Visit website Investor relations